Colorectal cancer: Tipping the scales

September 5, 2018, Ludwig Maximilian University of Munich
Colorectal cancer: Tipping the scales
Micrograph of an organoids, which were generated from intestinal epithelial cells cultered ex vivo. Ap4-deficient organoids formed less protrusions/crypts than Ap4 expressing organoids. Credit: H. Hermeking

The regulatory protein c-MYC plays an important role in promoting the development of many types of tumors. The c-MYC transcription factor controls the activity of a large number of genes involved in cell division, and its over-expression leads to excessive cell proliferation. A new study carried out by a team led by Professor Heiko Hermeking at the Institute of Pathology at LMU (and German Cancer Consortium) now shows that c-MYC induces the production of a transcription factor that increases the numbers of stem cells in the intestinal epithelium, and thereby contributes to the formation of adenomas in the colon. Their findings appear in the online journal Nature Communications.

In approximately 90 percent of patients that present with colon carcinoma, the expression of the c-MYC protein is strongly increased due to mutations in the APC/beta-catenin pathway. As a result, the genes activated by c-MYC are themselves upregulated. Among the targets of c-MYC is the gene AP4, which codes for the transcription factor of the same name (AP4). Transcription factors like c-MYC and AP4 act as regulatory switches that enable the genetic information encoded in specific segments of the DNA to be transcribed into messenger RNA, which programs the synthesis of the corresponding proteins. Hermeking and his colleagues had previously demonstrated that AP4 promotes the metastasis of colon tumors. "However, the normal function of the protein in the remained unknown, and whether or not it participates in primary tumorigenesis in the organ was unclear," Hermeking explains.

In order to investigate this further, the researchers turned to an experimental mouse model for hereditary adenomatous polyposis of the colon in humans. In this ApcMin strain of mice, which is particularly prone to developing colon cancer, the team deleted the Ap4 gene specifically in the colon epithelium. "It turned out that mice which lacked the Ap4 protein developed significantly fewer tumors and survived for 100 days longer, on average, than did the mice that could still synthesize it," says Hermeking. Surprisingly, the loss of Ap4 had no effect on the division rates of either normal or tumorous epithelial cells in the colon. Instead, deletion of Ap4 is associated with a reduction in the numbers of adult present in the tissue. "This finding confirms a recently proposed model, which postulates that the incidence of tumorigenesis is correlated with the number of stem cells in an organ. Stem cells are thus especially susceptible to malignant transformation," says Hermeking.

Further studies on cultured, tumor-derived, intestinal cells grown under conditions in which they form aggregations known as organoids and tumoroids validated the effect. Analysis of gene activity in these microstructures enabled the researchers to conclude that Ap4 acts on two crucial signaling pathways that regulate the balance between stem cell maintenance and differentiation, and tips the scales toward stem cells.

Explore further: Stem-cell niche for 10 billion colon cells a day

More information: Stephanie Jaeckel et al, Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells, Nature Communications (2018). DOI: 10.1038/s41467-018-06001-x

Related Stories

Stem-cell niche for 10 billion colon cells a day

June 6, 2018
Researchers at the University of Zurich have discovered the identity of the stem-cell niche of the colon. The niche comprises special cells that activate the stem cells of the adjacent intestinal epithelium and are responsible ...

Cancer metastasis: The unexpected perils of hypoxia

May 11, 2017
The low oxygen concentrations that prevail in many tumors enhance their propensity to metastasize to other tissues. Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich led by Professor Heiko Hermeking have now ...

SMAD4 clue to colon cancer

July 6, 2018
Chronic inflammation is a predisposing condition for colorectal cancer, the third leading cause of cancer-related deaths in the United States.

Why tumor cells leave home

June 11, 2013
(Medical Xpress)—Malignant cells can escape from primary tumors and colonize new sites in other tissues. In a new study, LMU researchers show how the transcription factor AP4 promotes the development of such metastatic ...

Why tumor cells go on dangerous tours

November 4, 2013
Tumors become highly malignant when they acquire the ability to colonize other tissues and form metastases. Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich have identified a factor that promotes metastasis ...

New target protein for colon cancer identified

July 18, 2018
Researchers at Boston University School of Medicine (BUSM) have identified a new potential target protein (c-Cbl) they believe can help further the understanding of colon cancer and ultimately survival of patients with the ...

Recommended for you

Treatment shown to improve the odds against bone marrow cancer

December 15, 2018
Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.